CITIUS ONCOLOGY, INC. - CTOR

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$9.419M
QoQ value delta ($000)
+$2.566M (+37.44%)
Implied price effect (QoQ)
-36.47%
Shares
Total shares
14,844,821
QoQ shares delta
+7,983,621 (+116.36%)
Total shares held by funds (by quarter)

Market chart (CTOR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 14 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
ARMISTICE CAPITAL, LLC 5,696 9,188,855 0.1%
BANK OF AMERICA CORP /DE/ 2,373 3,835,160 0.0%
VANGUARD GROUP INC 596 596,997 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 331 534,824 0.0%
GEODE CAPITAL MANAGEMENT, LLC 164 264,733 0.0%
VANGUARD FIDUCIARY TRUST CO 75 121,910 0.0%
IFP Advisors, Inc 66 107,424 0.0%
BlackRock, Inc. 29 47,454 0.0%
NORTHERN TRUST CORP 28 45,746 0.0%
STATE STREET CORP 26 42,900 0.0%
UBS Group AG 22 36,840 0.0%
Arkadios Wealth Advisors 7 11,666 0.0%
OSAIC HOLDINGS, INC. 6 10,125 0.0%
ROYAL BANK OF CANADA 0 186 0.0%
Caitong International Asset Management Co., Ltd 0 1 0.0%